Correlation between clostridium difficile bacterial load, commercial eal-time pcr cycle thresholds, and results of diagnostic tests ased on enzyme immunoassay and cell culture cytotoxicity assay

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3624-3630

  Dionne, Léa Laurence ^a   Raymond, Frédéric ^a   Corbeil, Jacques ^a   Longtin, Jean ^a   Gervais, Philippe ^a   Longtin, Yves ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIAL TOXIN A; BACTERIAL TOXIN B; GLUTAMATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; CELL CULTURE CYTOTOXICITY ASSAY; CLOSTRIDIUM DIFFICILE; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FECES ANALYSIS; GENE SEQUENCE; GENE TARGETING; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TCDB GENE; TOXIN ANALYSIS;

BACTERIAL LOAD; CELL CULTURE TECHNIQUES; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; FECES; HUMANS; IMMUNOENZYME TECHNIQUES; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84886508083     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01444-13     Document Type: Article

References (30)

1. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, ECDIS Study Group. 2011. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63-73.
2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
3. Kufelnicka AM, Kirn TJ. 2011. Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin. Infect. Dis. 52:1451-1457.
4. Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, Krishna S. 2008. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect. Dis. 8:777-784.
5. Wilcox MH, Planche T, Fang FC, Gilligan P. 2010. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48:4347-4353.
6. Peterson LR, Manson RU, Paule SM, Hacek DM, Robicsek A, Thomson RB, Jr, Kaul KL. 2007. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin. Infect. Dis. 45:1152-1160.
7. Deshpande A, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Pant C, Hernandez AV. 2011. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin. Infect. Dis. 53:e81-e90.
8. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455.
9. Goldenberg SD, Cliff PR, Smith S, Milner M, French GL. 2010. Twostep glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J. Hosp. Infect. 74:48-54.
10. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, Carroll KC. 2007. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 45:3601-3605.
11. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48:3719-3724.
12. Goldenberg SD, Gumban M, Hall A, Patel A, French GL. 2011. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 70:417-419.
13. Kvach EJ, Ferguson D, Riska PF, Landry ML. 2010. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J. Clin. Microbiol. 48:109-114.
14. Leslie JL, Cohen SH, Solnick JV, Polage CR. 2012. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing? Eur. J. Clin. Microbiol. Infect. Dis. 31:3295-3299.
15. Gyorke CE, Wang S, Leslie JL, Cohen SH, Solnick JV, Polage CR. 2012. Evaluation of fecal C. difficile load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J. Clin. Microbiol. 51:278-280.
16. Ryder AB, Huang Y, Li H, Zheng M, Wang X, Stratton CW, Xu X, Tang YW. 2010. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J. Clin. Microbiol. 48:4129-4134.
17. Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, Beaulieu C, Goulet D, Longtin J. 2013. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin. Infect. Dis. 56:67-73.
18. Naaber P, Stsepetova J, Smidt I, Ratsep M, Koljalg S, Loivukene K, Jaanimae L, Lohr IH, Natas OB, Truusalu K, Sepp E. 2011. Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients. J. Clin. Microbiol. 49:3656-3658.
19. Poirier L, Lamothe F, Vincelette J, Bourgault AM. 1991. Usefulness of semi-quantitative cultures in the diagnosis of Clostridium difficile associated disease. Eur. J. Clin. Microbiol. Infect. Dis. 10:770-772.
20. Delmee M, Van Broeck J, Simon A, Janssens M, Avesani V. 2005. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J. Med. Microbiol. 54(Pt 2):187-191.
21. Shanholtzer CJ, Willard KE, Holter JJ, Olson MM, Gerding DN, Peterson LR. 1992. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J. Clin. Microbiol. 30:1837-1840.
22. Gillespie S, Hawkey PM . 2006. Principles and practice of clinical bacteriology, 2nd ed. John Wiley & Sons, West Sussex, England.
23. Dionisio D (ed). 2003. Textbook-atlas of intestinal infections in AIDS. Springer, Milan, Italy.
24. Foster NF, Riley TV. 2012. Improved recovery of Clostridium difficile spores with the incorporation of synthetic taurocholate in cycloserinecefoxitin- fructose agar (CCFA). Pathology 44:354-356.
25. Boisvert S, Laviolette F, Corbeil J. 2010. Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies. J. Comput. Biol. 17:1519-1533.
26. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
27. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJ, Jolley KA, Kirton R, Peto TE, Rees G, Stoesser N, Vaughan A, Walker AS, Young BC, Wilcox M, Dingle KE. 2010. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 48:770-778.
28. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
29. Jump RL, Pultz MJ, Donskey CJ. 2007. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob. Agents Chemother. 51:2883-2887.
30. Nomanpour B, Ghodousi A, Babaei A, Abtahi H, Tabrizi M, Feizabadi M. 2011. Rapid, cost-effective, sensitive and quantitative detection of Acinetobacter baumannii from pneumonia patients. Iran. J. Microbiol. 3:162-169.